table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 outpatients
nirmatrelvir / ritonavir (Paxlovid) EPIC-HR

2 studies excluded by filtering options 0

9262 EPIC PEP, 2022 110risk of bias not avaialble
9263 EPIC-SR, 0 110risk of bias not avaialble

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons